Gene therapy for severe combined immune deficiency poised for European approval: If green-lighted, Strimvelis would provide additional treatment option for second most common form of disease
Am J Med Genet A. 2016 Aug;170(8):1955-6.
doi: 10.1002/ajmg.a.37752.